| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0024-3205(97)01117-X |
| P698 | PubMed publication ID | 9450507 |
| P50 | author | Julian Romero | Q60172928 |
| P2093 | author name string | J A Ramos | |
| R de Miguel | |||
| J J Fernández-Ruiz | |||
| P2860 | cites work | The separation of synaptic vesicles from nerve-ending particles (‘synaptosomes’) | Q24532177 |
| Cannabinoid receptor localization in brain | Q24558751 | ||
| (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability | Q28244400 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat | Q33260494 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| The cannabinoid receptor: biochemical, anatomical and behavioral characterization | Q36605535 | ||
| Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 | ||
| GABA-mediated control of rat neostriatal tyrosine hydroxylase revealed by intranigral muscimol | Q39118943 | ||
| Search for endogenous ligands of the cannabinoid receptor | Q40643774 | ||
| GABAB receptor activation partially inhibits N-methyl-D-aspartate-mediated tyrosine hydroxylase stimulation in rat striatal slices | Q41817380 | ||
| Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas | Q42451556 | ||
| Neurons of the substantia nigra reticulata receive a dense GABA-containing input from the globus pallidus in the rat. | Q44324835 | ||
| Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P. | Q44539554 | ||
| Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. | Q45080631 | ||
| Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. | Q45289172 | ||
| Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. | Q45290294 | ||
| GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. | Q47921750 | ||
| Dopamine and gamma-aminobutyric acid transporters: differential regulation by agents that promote phosphorylation | Q48121688 | ||
| Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment | Q48209713 | ||
| Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations | Q48272341 | ||
| Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent | Q48332786 | ||
| The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats | Q48444035 | ||
| Effects of repeated administration of estradiol benzoate on tubero-infundibular GABAergic activity in male rats | Q48500490 | ||
| γ-Aminobutyric acid (GABAB) receptor-mediated inhibition of tyrosine hydroxylase activity in the striatum of rat | Q48650718 | ||
| Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat. | Q48786464 | ||
| The dimethylheptyl derivative of (−)-Δ8-tetrahydrocannabinol reduces the turnover rate of gamma-aminobutyric acid in the septum and nucleus accumbens | Q48943260 | ||
| Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. | Q48962147 | ||
| Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2. | Q49018761 | ||
| Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system | Q49060851 | ||
| An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. | Q51139556 | ||
| Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. | Q52060269 | ||
| Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. | Q54001516 | ||
| Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study | Q68457920 | ||
| Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist | Q70911264 | ||
| Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand | Q71040771 | ||
| Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata | Q71735623 | ||
| Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection | Q72001109 | ||
| delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats | Q72270865 | ||
| The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons | Q72302141 | ||
| GABA-like Actions of Levonantradol | Q72912435 | ||
| Tetrahydrocannabinol potentiates reserpine-induced hypokinesia | Q72916142 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 351-363 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake | |
| P478 | volume | 62 |
| Q42517324 | Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. |
| Q34605794 | CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum |
| Q48407695 | Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry |
| Q34248777 | Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output |
| Q42469712 | Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol |
| Q42490465 | Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice |
| Q33695713 | Cannabinoids, endogenous ligands and synthetic analogs |
| Q34549222 | Cannabis and cannabinoid receptors: from pathophysiology to therapeutic options |
| Q34515581 | Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis |
| Q48315314 | Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice |
| Q45025701 | Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline |
| Q43754879 | Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration |
| Q42844506 | Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys |
| Q42538098 | Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs |
| Q34155664 | Effects of nefiracetam on spatial memory function and acetylcholine and GABA metabolism in microsphere-embolized rats |
| Q43064653 | Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine |
| Q48136699 | Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide |
| Q48171307 | Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response |
| Q28145410 | Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol |
| Q34750566 | Functions of cannabinoid receptors in the hippocampus |
| Q34320139 | Hu 210: a potent tool for investigations of the cannabinoid system. |
| Q73129294 | Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina |
| Q28203208 | Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets |
| Q88971676 | Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users |
| Q45305400 | Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease |
| Q46943485 | Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol |
| Q39122422 | Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum |
| Q42474019 | Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. |
| Q30830239 | Pre- and postsynaptic localization of GABA(B) receptors in the basal ganglia in monkeys |
| Q28363375 | Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons |
| Q43815277 | Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms |
| Q35840095 | Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC. |
| Q34267133 | The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ an |
| Q52167130 | The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat. |
| Q28137626 | The effects of cannabinoids on the brain |
| Q34786832 | The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. |
| Q37416382 | The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen |
| Q24522320 | The neurobiology and evolution of cannabinoid signalling |
| Q42487505 | Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen |
Search more.